Last reviewed · How we verify
NCT06284538: WOUND-H
Study to Evaluate the Effectiveness of a Medical Device Based on Hyaluronic Acid in Wounds
NA trial testing NOVA.EMOSTOP RE-EPITHELIZING in Wound Healing Disorder in 112 participants. Status unknown.
31 July 2024
Quick facts
| Lead sponsor | Nova Argentia S.r.l. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 112 |
| Start date | 15 January 2024 |
| Primary completion | 31 July 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- NOVA.EMOSTOP RE-EPITHELIZING
Conditions studied
- Wound Healing Disorder — all drugs for Wound Healing Disorder →
Sponsor
Nova Argentia S.r.l.
Who can join
18 and older, any sex, with Wound Healing Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the study is to evaluate the safety and performance of a Class IIB medical device based on linear hyaluronic acid used in the treatment of post-surgical wounds. The outcomes of the study are the improvement of wound healing assessed through the Clinical Healing score (score from 0 to 5), which includes the evaluation of: redness, edema, suppuration, healthy granulation tissue and signs of re-epithelialization; the percentage of patients with completely healed wounds at day 30 post-treatment; the pain perceived by the patient when changing the dressing; the frequency of adverse events.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06284538
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06284538 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nova Argentia S.r.l.
- Last refreshed: 29 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06284538.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing